本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Trinity Biotech plc

0.7510
-0.0167-2.18%
成交量:6,991.00
成交額:5,432.33
市值:1,394.33萬
市盈率:-0.33
高:0.7850
開:0.7850
低:0.7502
收:0.7677
資料載入中...
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/17

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/28

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/28

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/09/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/13

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/15

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/10/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/05/14

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/05/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]